Metsios, George S. http://orcid.org/0000-0001-5359-0436
Fenton, S. A. M.
Tzika, K.
Moe, R. H.
Fragoulis, G. E.
Vlieland, T. P. M. Vliet
Nikiphorou, E.
Van den Ende, C. H. M.
Fatouros, I.
van der Esch, M.
Niedermann, K.
Stavropoulos-Kalinoglou, A.
van Zanten, J. J. C. S. Veldhuijzen
Brodin, N.
O’Brien, C. M.
Koutedakis, Y.
Kennedy, N.
Swinnen, T. W.
Bostrom, C.
Kitas, G. D.
,
Funding for this research was provided by:
European League Against Rheumatism (HPR043)
Article History
Received: 17 October 2022
Revised: 17 January 2023
Accepted: 19 January 2023
First Online: 6 March 2023
Declarations
:
: EN has received speaker honoraria/participated in advisory boards for Celltrion, Pfizer, Sanofi, Gilead, Galapagos, AbbVie, Lilly, Fresenius and holds research grants from Pfizer and Lilly.GEF has received honoraria/speaker fees from Abbvie, Novartis, Pfizer, UCB, AEnorasis, Genesis.All other authors have nothing to declare.